Cell Salvage in Oncological Surgery, Peripartum Haemorrhage and Trauma

Oncological surgery, obstetric haemorrhage and severe trauma are the most challenging conditions for establishing clinical recommendations use of cell salvage. When likelihood allogeneic transfusion is high, intraoperative this blood-saving technique would be justified, but specific patient selection criteria needed. The main concerns in case oncological surgery reinfusion tumour cells, thereby increasing risk metastasis. This threat could minimized, which may help to rationalize its indication. In peripartum haemorrhage, salvage has not proven cost-effective, damage control techniques have been developed, and, given fetomaternal alloimmunization amniotic fluid embolism, it increasingly out use. trauma, bleeding originate from multiple sites, coagulopathy develop, should evaluated whether re-transfusion autologous blood collected uncontaminated organ cavities feasible. General safety measures include washing recovered passage through leukocyte depletion filters. To date, no well-defined indications established these pathologies, with accurate selective implementation, become safe effective. Randomized trials urgently